Shock drug dose linked to death risk in ICU patients
NCT ID NCT05032261
First seen Dec 31, 2025 · Last updated May 21, 2026 · Updated 23 times
Summary
This study examined 100 critically ill patients with circulatory shock in the ICU who received norepinephrine, a drug that raises blood pressure. Researchers wanted to see if a certain dose of norepinephrine was linked to a higher risk of death within 5 days. They also looked at how long patients needed the drug and the total amount given, aiming to create a score that could help doctors know when higher doses may no longer help.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRCULATORY COLLAPSE AND SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
Conditions
Explore the condition pages connected to this study.